Andreas Halvorsen (Trades, Portfolio), founder and main investment decision officer of Viking Global Buyers LP, disclosed this week he additional than tripled the firm’s stake in aTyr Pharma inc. (NASDAQ:Existence).
Prior to founding the Greenwich, Connecticut-based hedge fund, Halvorsen worked as senior handling director and the director of equities at Julian Robertson (Trades, Portfolio)’s Tiger Administration LLC. In accordance to its internet site, Viking manages somewhere around $31 billion in cash and employs a exploration-intense, prolonged-term investment decision strategy. The fund selects community and personal fairness securities utilizing basic analysis, i.e., based on a extensive assessment of business designs, high-quality of business management and analysis of cyclical and secular business trends.
In accordance to GuruFocus Authentic-Time Picks, a Quality element, Halvorsen reported a keeping of 816,728 shares as of Dec. 31, 2019, up 256.21% from the 3rd-quarter 2019 keeping of 229,283 shares.
Although shares traded all-around $4.seventeen on the Dec. 31 transaction day, shares of aTyr shut at $3.ninety six on Tuesday, somewhere around 5% underneath the transaction-day cost.
The San Diego-based biotech business discovers and develops ground breaking medications based on novel immunological pathways. The company’s major drug, ATYR1923, focuses on deregulating the innate and adaptive immune reaction in inflammatory ailment instances, aiding people with interstitial lung health conditions. aTyr entered in January a license with Kyorin Pharmaceutical Co., a subsidiary of Kyorin Holdings Inc. (TSE:4569), for the enhancement and commercialization of ATYR1923 in Japan.
On Feb. 6, the business declared in a push launch the pricing of an underwritten community supplying of 4,235,294 shares of frequent inventory at $4.twenty five for every share.
Enterprise economical energy position
In accordance to GuruFocus, aTyr has somewhere around $two.seventy seven in funds for every $1 in credit card debt, a ratio that underperforms sixty six.39% of global rivals. The business stated in its January prospectus that as of September 2019, the company’s term financial loans consisted of somewhere around $9.3 billion principal, owing to be repaid ratably on a month to month foundation until finally November 2020. On top of that, the business has a $1.eight million payment owing in the fourth quarter of 2020.
Jim Simons (Trades, Portfolio)’ Renaissance Technologies also has a keeping in aTyr.
GuruFocus Authentic-Time Picks mentioned a number of other trades for Halvorsen, together with reductions in Moderna Inc. (NASDAQ:MRNA) and Chewy Inc. (NYSE:CHWY).
Disclosure: No positions.
Study additional below:
Not a Quality Member of GuruFocus? Sign up for a absolutely free 7-day trial below.
About the creator:
I am an editorial researcher at GuruFocus. I have a Master’s in Finance from SMU, and I enjoy producing reports on economical trends and investor portfolios. Abide by me on Twitter at @JamesLiGuru!
Go to James Li’s Internet site